Biopharma: Cutting-edge therapeutics, drug discovery, and biological technologies developed to address critical health challenges.
Digital Health & Creative Works: Innovations in digital platforms, software, health informatics, and media designed to enhance patient care and healthcare operations.
MedTech: Advanced medical devices and diagnostics that improve patient outcomes and streamline clinical procedures.
The Zucker Institute for Innovation Commercialization (ZI) independently evaluates and manages the intellectual
assets owned and generated by MUSC.
© 2025 Zucker Institute for Innovation Commercialization. All rights reserved.